Código QR (código de barras bidimensional)

SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have cardioprotective effects without acting directly on the myocardium. Objectives: The purpose of the study was to evaluate the impact of SGLT2i on myocardial glucose utilization. Methods: This retrospective propensity-matched cohort...

ver descrição completa

Na minha lista:
Principais autores: Brett W. Sperry, MD, Yazan Almohtasib, MD, Ramy Ghaly, MD, Mohammad Abdel Jawad, MD, Andrew J. Sauer, MD, Timothy M. Bateman, MD
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2025-08-01
coleção:JACC: Advances
Assuntos:
cardiomyopathy
diabetes
fatty acids
heart failure
ketone body
metabolic syndrome
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2772963X25004405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados